Essex Bio-Technology Limited

SEHK:1061 주식 보고서

시가총액: HK$1.5b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Essex Bio-Technology 대차 대조표 상태

재무 상태 기준 확인 6/6

Essex Bio-Technology 의 총 주주 지분은 HK$1.9B 이고 총 부채는 HK$271.9M, 이는 부채 대 자기자본 비율을 14.1% 로 가져옵니다. 총자산과 총부채는 각각 HK$2.8B 및 HK$903.8M 입니다. Essex Bio-Technology 의 EBIT는 HK$351.6M 이며 이자보상배율은 -310.8 입니다. HK$515.0M 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

15.2%

부채 비율

HK$306.54m

부채

이자 보상 비율-46.3x
현금HK$600.62m
주식HK$2.02b
총 부채HK$950.33m
총 자산HK$2.97b

최근 재무 상태 업데이트

Recent updates

Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29
Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's

Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

May 06
Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)

Mar 21
Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)

Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet

Dec 07
Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Dec 07
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04

Aug 25
Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04

Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?

Jun 22
Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?

Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

May 02
Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Mar 30
Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Jun 29
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Is Essex Bio-Technology (HKG:1061) A Risky Investment?

Mar 31
Is Essex Bio-Technology (HKG:1061) A Risky Investment?

If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

Mar 13
If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Feb 15
How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?

Jan 25
Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?

Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Jan 04
Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Dec 13
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters

Nov 23
Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters

재무 상태 분석

단기부채: 1061 의 단기 자산 ( HK$1.2B )이 단기 부채( HK$810.7M ).

장기 부채: 1061 의 단기 자산( HK$1.2B )이 장기 부채( HK$93.0M ).


부채 대 자본 내역 및 분석

부채 수준: 1061 총 부채보다 더 많은 현금을 보유하고 있습니다.

부채 감소: 1061 의 부채 대 자기자본 비율은 지난 5년간 20.4% 에서 14.1% 로 감소했습니다.

부채 범위: 1061 의 부채는 영업 현금 흐름 ( 124.7% )에 의해 잘 충당되었습니다.

이자 보장: 1061 지불하는 것보다 더 많은 이자를 벌기 때문에 이자 지불 보장은 문제가 되지 않습니다.


대차 대조표


건강한 기업 발견하기